期刊文献+

152例肝移植术后肝功能异常的肝活检 被引量:2

Liver biopsy as a means to investigate abnormal liver function in 152 liver recipients
原文传递
导出
摘要 目的评价肝活检在明确肝移植术后肝损害病因中的作用,分析组织学诊断存在误差的常见原因,进一步提高肝活检的准确性,以利临床治疗。方法260例肝活检来自于152例肝移植受者,术后出现临床无法解释的肝功能异常,肝功能检测结果高于正常值的2倍以上。回顾组织学改变及最终的临床诊断,评价相符程度。结果大部分的组织学诊断与最终的临床诊断相符,有7例组织学改变为胆管炎后经进一步临床检查证实4例为血管并发症、2例为败血症、1例为保存性损伤。2例组织学诊断为保存性损伤的病例后证实为药物性肝损害。结论移植后肝活检可明确许多肝功能异常的原因;评判病变的严重程度,指导临床治疗;对一些复杂病例应将以往的活检和整个临床病程、其他实验室检查及影像学检查进行综合考虑,可提高诊断的准确性。 Objective To investigate accuracy of liver biopsy in identification of the liver damage after liver transplantation and to analyze the factors that induce the errors in histological diagnosis for improvement of liver biopsy and of treatment. Methods A total of 260 liver biopsies in 152 patients were performed for unexplained abnormalities in liver function test results which were more than twice the upper limit of normal. Histological findings were investigated and compared with final clinical diagnosis to show the concordance. Results Most of the histological suggestions were coordinate with final clinical diagnosis. Seven biopsies with histological findings of cholangitis were later found to be vascular complication (n=4), septicemia (n=2), preservation injury (n=1) as shown by further clinical assessment. Two biopsies supposed to be preservation injury were related to drug toxicity (n=2). Conclusion Liver biopsy after transplantation can identify many causes of liver dysfunction and severity grade of damage so as to guide patient management. Previous biopsies, the clinical course, imaging and laboratory test are also helpful to make precise histological diagnoses.
出处 《中华肝胆外科杂志》 CAS CSCD 2007年第7期449-451,共3页 Chinese Journal of Hepatobiliary Surgery
关键词 肝移植 肝活检 肝功能异常 Liver transplantation Liver biopsy Abnormal liver function
  • 相关文献

参考文献10

  • 1Odze RD, Goldblum JR, Crawford JM. Surgical pathology of the GT tract, liver, biliary tract, and pancreas. Philadelphia: WB Saunder, 2004. 833-862.
  • 2Demetris AJ, Batts KP, Dhillon AP, et al. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology, 1997, 25: 658-663.
  • 3Demetris AJ, Adams D, Bellamy C, et al. Update of the international Banff schema for the international Banff schema for liver allograft rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An in ternational panel. Hepatology, 2000, 31:792-799.
  • 4Vierling TM. Immunology of acute and chronic hepatic allograft rejection. Liver Transplant Surg, 1999, 5: S1-S20.
  • 5Demetris AJ, Ruppert K, Dvorchik I, et al. Real time monitoring of acute liver allograft rejection using the Banff schema. Transplantation, 2002, 74:1290-1296.
  • 6Wiesner RH, Menon KVN. Late hepatic allograft dysfunction. Liver Transpl, 2001, 7(Suppl 1): S60-S73.
  • 7Bhattacharjya S, Gunson BK, Mirza DF, et al. Delayed hepatic artery thrombosis in adult orthotopic liver transplantation-A 12-year experience. Transplantation, 2001, 71:1592-1596.
  • 8Van Den Heuvel MC, De Jong KP, Van Den Horst MLC, et al. Impaired regeneration of biliary cells in human chronic liver allograft rejection. Special emphasis on the role of the finest branches of the biliary tree. Liver Transpl, 2004, 10:28-35.
  • 9Benari Z, Pappo O, Mor E. Intrahepatic cholestasis after liver transplantation. Liver Transpl, 2003, 9: 1005-1018.
  • 10Gouw ASH, Van Den Heuvel MC, Van Den Berg AP, et al. The significance of parenehymal changes of acute cellular rejection predicting chronic liver graft rejection. Transplantation, 2002,73: 243-247.

同被引文献35

  • 1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1931
  • 2孟家榕,郑瑞丹,张闽峰,郭以河,林明珠,戴太监.非酒精性脂肪性肝炎肝穿刺临床病理分析[J].南方医科大学学报,2006,26(3):339-341. 被引量:3
  • 3McCaughan GW,Davies JS,Waugh JA,et al.A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection:the use of monoclonal antibodies and double immunolabeling.Hepatology,1990,12s 1305-1313.
  • 4Demetris A,Adams D,Bellamy C,et al.Update of the Inter-national Banff Schema for Liver Allograft Rejection:working recommendations for the histopathologic staging and reporting of chronic rejection.An International Panel.Hepatology,2000,31:792-799.
  • 5Sarwal M,Chua MS,Kambam N,et al.Molecular heteroge-neity in acute renal allograft rejection identified by DNA mi-croarray profiling.N Engl J Med,2003,349:125-138.
  • 6Lehnhardt A,Mengel M,Pape L,et al.Nodular B-cell aggre-gates associated with treatment refractory renal transplant re-jection resolved by rituximab.Am J Transplant,2006,6:847-851.
  • 7Alausa M,Almagro U,Siddiqi N,et al.Refractory acute kid-ney transplant rejection with CD20 graft infiltrates and suc-cessful therapy with rituximab.Clin Transplant,2005,19:137-140.
  • 8Arce E,Jackson DG,Gill MA,et al.Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus.J Immu-nol,2001,167:2361-2369.
  • 9Desvaux D,Le Gouvello S,Pastural M,et al.Acute renal al-lograft rejections with major interstitial oedema and plasma cell-rich infiltrates:high gamma-interferon expression and poor clinical outcome.Nephrol Dial Transplant,2004,19:933-939.
  • 10Horacio E,Adrogue,Soltero L,et al.Immunoglobulin thera-py for plasma cell-rich rejection in the renal allograft.Trans-plantation.2006,82:567-569.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部